Cellviva, LLC
San Jose, CA, US· latest recorded location
Cellviva, LLC is named on 0 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 0
- Published applications
- 4
- Inventors
- 3
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
By publication year.
Technology areas
Share of 4 documents
Recent patents
No granted patents yet.
- Systems, devices and methods for applying anti-vegf compounds and using such compounds to treat skin conditions28 Aug 2025US 2025/0269017 A1
- Methods Of Treatment Of Pterygium Using An Anti-VEGF Agent8 May 2025US 2025/0144206 A1
- Compositions comprising anti-vegf and nanoparticles and methods of using the same for the treatment of abnormal or excessive angiogenesis1 Jun 2023US 2023/0167170 A1
- Systems, devices and methods for applying anti-vegf compounds and using such compounds to treat skin conditions12 Dec 2019US 2019/0374638 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.